Literature DB >> 21301480

Human FoxP3(+)CD4(+) regulatory T cells: their knowns and unknowns.

Makoto Miyara1, Shimon Sakaguchi.   

Abstract

Human regulatory T cells (Tregs) expressing the transcription factor FoxP3 play indispensable roles for the maintenance of immunological self-tolerance and immune homeostasis. In this review, we discuss immunological characteristics of human FoxP3(+) Tregs and to what extent they are similar to or different from the murine counterparts. We also discuss important issues that remain to be addressed in the field to better understand the pathophysiology of autoimmune disease and to build solid basis for immunotherapies targeting FoxP3(+) Tregs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21301480     DOI: 10.1038/icb.2010.137

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  81 in total

1.  Necrotising enterocolitis is characterised by disrupted immune regulation and diminished mucosal regulatory (FOXP3)/effector (CD4, CD8) T cell ratios.

Authors:  Jörn-Hendrik Weitkamp; Tatsuki Koyama; Michael T Rock; Hernan Correa; Jeremy A Goettel; Pranathi Matta; Kyra Oswald-Richter; Michael J Rosen; Brian G Engelhardt; Daniel J Moore; D Brent Polk
Journal:  Gut       Date:  2012-01-20       Impact factor: 23.059

2.  CTLA-4 blockade with ipilimumab: long-term follow-up of 177 patients with metastatic melanoma.

Authors:  Peter A Prieto; James C Yang; Richard M Sherry; Marybeth S Hughes; Udai S Kammula; Donald E White; Catherine L Levy; Steven A Rosenberg; Giao Q Phan
Journal:  Clin Cancer Res       Date:  2012-01-23       Impact factor: 12.531

3.  CD4 regulatory T cells augment HIV-1 expression of polarized M1 and M2 monocyte derived macrophages.

Authors:  Tanya O Robinson; Mingce Zhang; Christina Ochsenbauer; Lesley E Smythies; Randall Q Cron
Journal:  Virology       Date:  2017-01-31       Impact factor: 3.616

Review 4.  Targeted immune interventions for type 1 diabetes: not as easy as it looks!

Authors:  Mark R Rigby; Mario R Ehlers
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-08       Impact factor: 3.243

Review 5.  TREG-cell therapies for autoimmune rheumatic diseases.

Authors:  Makoto Miyara; Yoshinaga Ito; Shimon Sakaguchi
Journal:  Nat Rev Rheumatol       Date:  2014-07-01       Impact factor: 20.543

Review 6.  Regulation generation: the suppressive functions of human regulatory T cells.

Authors:  Wendy A Goodman; Kevin D Cooper; Thomas S McCormick
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

7.  T-cell depletion: from positive selection to negative depletion in adult patients.

Authors:  F Aversa
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

8.  Next generation HLA-haploidentical HSCT.

Authors:  M F Martelli; M D Ianni; L Ruggeri; F Falzetti; A Carotti; Y Reisner; A Velardi
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

9.  Correlation between IL-17A/F, IL-23, IL-35 and IL-12/-23 (p40) levels in peripheral blood lymphocyte cultures and disease activity in Behcet's patients.

Authors:  Cemile Sonmez; Aysegul Atak Yucel; Turan Hilmi Yesil; Hamit Kucuk; Berna Sezgin; Ridvan Mercan; Ahmet Eftal Yucel; Gulderen Yanikkaya Demirel
Journal:  Clin Rheumatol       Date:  2018-03-20       Impact factor: 2.980

10.  The Tumor Microenvironment of Bladder Cancer.

Authors:  Ken Hatogai; Randy F Sweis
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.